Clinical Trial Update: Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from Nestlé SPN reports on the effects of hesperidin on bone biomarkers in postmenopausal women with osteopenia or osteoporosis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• Hesperidin (Hesperidin)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Osteopenia, Osteoporosis | Phase 2 | Status: COMPLETED